Clinical Trials

500 enrolled

Hepatoblastoma

NCT05806931 2026-03-18

SCOTI

50 enrolled

Colonic Neoplasms, Rectal Neoplasms

NCT06077591 2026-03-18

PDO

40 enrolled

Carcinoma, Hepatocellular, Colorectal Neoplasms

NCT06621472 2026-03-18

Retrolaminar Block Versus Subcostal Transversus Abdominis Plane Block in Liver Resection Surgery

90 enrolled

Carcinoma, Hepatocellular

NCT06637462 2026-03-18

A Study of Response to Standard Treatment Before Surgery in People With Rectal Cancer

30 enrolled

Rectal Neoplasms

NCT06648057 2026-03-18

Investigation of Predictive Biomarkers in Patients With Advanced BTC Treated With Lenvatinib Plus Pembrolizumab

100 enrolled

Biliary Tract Neoplasms, Cholangiocarcinoma

NCT06802991 2026-03-18

Optimised Post-discharge Care in Older Patients After Surgery for Colon Cancer (ERAS 3.0)

60 enrolled

Frailty, Colonic Neoplasms

NCT07010497 2026-03-18

IAPETUS

33 enrolled

Carcinoma, Hepatocellular

NCT07142226 2026-03-18

Role of ctDNA in Genetic Profiling & Outcomes for Advanced BTC

200 enrolled

Biliary Tract Neoplasms

NCT07151118 2026-03-18

ctDNA in Genetic Profiling and Clinical Outcomes of Advanced Biliary Tract Cancer

100 enrolled

Biliary Tract Neoplasms

NCT03384238 2026-03-17

Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery

27 enrolled

Pancreatic Adenocarcinoma

NCT03965234 2026-03-17

Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases

99 enrolled

GastrointestinalSarcoma

Bone Neoplasms, Sarcoma, Colorectal Neoplasms

NCT06205836 2026-03-17

Cemiplimab With or Without Fianlimab to Treat Older Patients With Localized or Locally Advanced MSI-H Colorectal Cancer

44 enrolled

Adenocarcinoma, Carcinoma, Colorectal Neoplasms

NCT06336902 2026-03-17

Botensilimab Plus Balstilimab and Fasting Mimicking Diet Plus Vitamin C for Patients With KRAS-Mutant Metastatic Colorectal Cancer

15 enrolled

Colorectal Neoplasms

NCT06418204 2026-03-17

COSMIC

BreastDermatologicGastrointestinalLymphoidThoracic

2,000 enrolled

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Lymphoma, Non-Hodgkin, Melanoma, Colorectal Neoplasms

NCT07215624 2026-03-17

STOP-VTE

500 enrolled

Gastrointestinal Neoplasms, Urogenital Neoplasms

NCT07477522 2026-03-17

Effects of High-Fiber Diet on Gut Microbiota, Metabolism, and Immune Microenvironment in Solid Tumor Patients: A Clinical Study

25 enrolled

Disease, Feeding Behavior, Colorectal Neoplasms

NCT07478731 2026-03-17

MA-CRC-II-018

48 enrolled

Colorectal Neoplasms

NCT04767568 2026-03-16

PREDICT-IRFC

400 enrolled

Colorectal Neoplasms

NCT04808323 2026-03-16

MRI-Guided Adaptive Radiation Therapy for Organ Preservation in Rectal Cancer

22 enrolled

Rectal Neoplasms

NCT05468359 2026-03-16

Safety and Efficacy of Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor Patients

64 enrolled

Fibrolamellar hepatocellular carcinoma, Carcinoma, Hepatocellular, Neoplasms

NCT05528952 2026-03-16

TERTIO

105 enrolled

Carcinoma, Hepatocellular

NCT06125769 2026-03-16

LITALHICA

50 enrolled

Klatskin Tumor

NCT06756074 2026-03-16

Reinforced Pancreaticojejunostomy With or Without glubran2

100 enrolled

Pancreatic Fistula, Pancreatic Neoplasms

NCT06796114 2026-03-16

PREDICT-HCC

120 enrolled

Carcinoma, Hepatocellular

NCT07299071 2026-03-16

IA-COLO 2

592 enrolled

Intestinal Polyps, Colorectal Neoplasms

NCT07472686 2026-03-16

iCARE4Lynch

400 enrolled

Colorectal Neoplasms, Hereditary Nonpolyposis, Neoplasms

NCT07474103 2026-03-16

SCRT-NALIRIXELOX+Sintilimab as TNT for High-Risk LARC

49 enrolled

Rectal Neoplasms

NCT01804634 2026-03-13

Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

CNSGastrointestinalSarcoma

60 enrolled

Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Ewing, Osteosarcoma, Hepatoblastoma

NCT05285358 2026-03-13

Pressurized Intraperitoneal Aerosolized Nab-Paclitaxel in Combination With Gemcitabine and Cisplatin for the Treatment of Biliary Tract Cancer Patients With Peritoneal Metastases

12 enrolled

Gallbladder Neoplasms, Cholangiocarcinoma

NCT05901519 2026-03-13

A Pilot Study of Liver Protection Using Prednisone for Patients Receiving Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma

20 enrolled

Carcinoma, Hepatocellular

NCT06408220 2026-03-13

Risk Assessment Evaluation for Identifying Participants at High Risk for Stomach Cancer

240 enrolled

Stomach Neoplasms

NCT06479239 2026-03-13

Panc 002

23 enrolled

Pancreatic Neoplasms

NCT07209787 2026-03-13

SIS-Reinforced vs. Conventional Anastomosis for Mid-to-Low Rectal Cancer: A Multicenter RCT on Anastomotic Leak

Phase 4 Recruiting

966 enrolled

Rectal Neoplasms

NCT07320586 2026-03-13

Carilizumab and Albumin Paclitaxel for Second-line Treatment of Advanced Gastric Cancer

40 enrolled

Stomach Neoplasms

NCT07469319 2026-03-13

BISHOP

617 enrolled

Fibrosis, Carcinoma, Hepatocellular

NCT07469709 2026-03-13

PRO-ACTIVE

BreastDermatologicGastrointestinalGynecologicThoracic

850 enrolled

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Melanoma, Ovarian Neoplasms

NCT04668872 2026-03-12

Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation

80 enrolled

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT05095714 2026-03-12

FASTRAK

944 enrolled

Fibrosis, Carcinoma, Hepatocellular, Liver Neoplasms

NCT05269381 2026-03-12

PNeoVCA

BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckSarcomaThoracic

132 enrolled

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Carcinosarcoma, Uterine Cervical Neoplasms, Carcinoma, Hepatocellular, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Carcinoma, Merkel Cell, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT05985954 2026-03-12

Open-label Phase 1b Study of Ulixertinib and Cetuximab or Ulixertinib in Combination With Cetuximab and Encorafenib in Patients With Unresectable or Metastatic Colorectal Cancer Who Have Previously Received EGFR or BRAF-directed Therapy

27 enrolled

Colorectal Neoplasms

NCT06349642 2026-03-12

ELEPHAS-04